E3 ubiquitin ligases in cancer and implications for therapies

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Metastasis Review

• Publication date

  2017-10-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10555-017-9703-zPMID 29043469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma

  2017cited by this paper
• HERC1 mutations in idiopathic intellectual disability.

  2017cited by this paper
• Reciprocal Regulation between 53BP1 and the Anaphase-Promoting Complex/Cyclosome Is Required for Genomic Stability during Mitotic Stress.

  2017cited by this paper
• miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7.

  2017cited by this paper
• Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non–small cell lung cancer

  2017cited by this paper
• Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer

  2016cited by this paper
• Types of Ubiquitin Ligases.

  2016cited by this paper
• Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP

  2016cited by this paper
• RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.

  2016cited by this paper
• Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.

  2016cited by this paper
• Elevated expression of WWP2 in human lung adenocarcinoma and its effect on migration and invasion.

  2016cited by this paper
• Mitochondrial dysfunction in Parkinson’s disease

  2016cited by this paper
• Insights into APC/C: from cellular function to diseases and therapeutics

  2016cited by this paper
• Recent advances in SCF ubiquitin ligase complex: Clinical implications.

  2016cited by this paper
• Involvement of F-BOX proteins in progression and development of human malignancies.

  2016cited by this paper
• Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness

  2016cited by this paper
• miR-93 promotes TGF-β-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells

  2016cited by this paper
• Look Out Autophagy, Ubiquilin UPS Its Game.

  2016cited by this paper
• The role of ubiquitin-proteasome pathway in spermatogenesis.

  2016cited by this paper
• Functional and pathological relevance of HERC family proteins: a decade later

  2016cited by this paper
• MASTL promotes cyclin B1 destruction by enforcing Cdc20-independent binding of cyclin B1 to the APC/C

  2015cited by this paper
• Nek2A destruction marks APC/C activation at the prophase‐to‐prometaphase transition by spindle‐checkpoint‐restricted Cdc20

  2015cited by this paper
• The MDM2 RING Domain and Central Acidic Domain Play Distinct Roles in MDM2 Protein Homodimerization and MDM2-MDMX Protein Heterodimerization*

  2015cited by this paper
• WWP1 as a potential tumor oncogene regulates PTEN-Akt signaling pathway in human gastric carcinoma

  2015cited by this paper
• NEDD4-2 (NEDD4L): the ubiquitin ligase for multiple membrane proteins.

  2015cited by this paper
• The E3 ligase Itch in immune regulation and beyond

  2015influential reference
• Targeting ubiquitination for cancer therapies.

  2015cited by this paper
• Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis

  2015cited by this paper
• Atomic structure of the APC/C and its mechanism of protein ubiquitination

  2015cited by this paper
• Knockdown of WWP1 inhibits growth and invasion, but induces apoptosis of osteosarcoma cells.

  2015cited by this paper
• Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress.

  2015cited by this paper
• Targeting the ubiquitin pathway for cancer treatment.

  2015cited by this paper
• STRUCTURAL AND FUNCTIONAL ANALYSIS

  2015cited by this paper
• DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L

  2015cited by this paper
• MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7

  2015cited by this paper
• NEDD4L regulates convergent extension movements in Xenopus embryos via Disheveled-mediated non-canonical Wnt signaling.

  2014cited by this paper
• HERC2/USP20 coordinates CHK1 activation by modulating CLASPIN stability

  2014cited by this paper
• Roles of F-box proteins in cancer

  2014cited by this paper
• Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C

  2014cited by this paper
• RBR E3‐ligases at work

  2014cited by this paper
• Mammalian HECT ubiquitin-protein ligases: biological and pathophysiological aspects.

  2014cited by this paper
• Degradation of the Deubiquitinating Enzyme USP33 Is Mediated by p97 and the Ubiquitin Ligase HERC2*

  2014cited by this paper
• FBXW7 mutations in melanoma and a new therapeutic paradigm.

  2014cited by this paper
• MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.

  2014cited by this paper
• WWP2: A Multifunctional Ubiquitin Ligase Gene

  2014cited by this paper
• HERC2 Targets the Iron Regulator FBXL5 for Degradation and Modulates Iron Metabolism

  2014cited by this paper
• Mutational spectrum of adult T-ALL

  2014cited by this paper
• Pathobiological properties of the ubiquitin ligase Nedd4L in melanoma

  2014cited by this paper
• The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway

  2014cited by this paper
• Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins

  2014cited by this paper
• FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.

  2014cited by this paper
• BCA2 is differentially expressed in renal oncocytoma: an analysis of 158 renal neoplasms

  2013cited by this paper
• Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development.

  2013cited by this paper
• The genetic landscape of high-risk neuroblastoma

  2013cited by this paper
• Regulation of metformin response by breast cancer associated gene 2.

  2013cited by this paper
• The emerging family of CULLIN3‐RING ubiquitin ligases (CRL3s): cellular functions and disease implications

  2013cited by this paper
• Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension.

  2013cited by this paper
• NEDD4L Is Downregulated in Colorectal Cancer and Inhibits Canonical WNT Signaling

  2013cited by this paper
• Cullin-RING Ligases as attractive anti-cancer targets.

  2013cited by this paper
• p53 Ubiquitination and proteasomal degradation.

  2013cited by this paper
• MDM2, MDMX and p53 in oncogenesis and cancer therapy

  2013cited by this paper
• Ube3a/E6AP is involved in a subset of MeCP2 functions.

  2013cited by this paper
• Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.

  2013cited by this paper
• The TOMM machinery is a molecular switch in PINK1 and PARK2/PARKIN-dependent mitochondrial clearance

  2013cited by this paper
• CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer

  2013cited by this paper
• NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway.

  2013cited by this paper
• Smurf E3 ubiquitin ligases at the cross roads of oncogenesis and tumor suppression.

  2013cited by this paper
• Spotlight on the role of COP1 in tumorigenesis

  2012cited by this paper
• Ubiquitin-based anticancer therapy: Carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors☆

  2012cited by this paper
• Erioflorin Stabilizes the Tumor Suppressor Pdcd4 by Inhibiting Its Interaction with the E3-ligase β-TrCP1

  2012cited by this paper
• Effects of partner proteins on BCA2 RING ligase activity

  2012cited by this paper
• Triggering Fbw7-Mediated Proteasomal Degradation of c-Myc by Oridonin Induces Cell Growth Inhibition and Apoptosis

  2012cited by this paper
• Overexpression of CDC20 predicts poor prognosis in primary non‐small cell lung cancer patients

  2012cited by this paper
• The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseases

  2012cited by this paper
• Investigating metformin for cancer prevention and treatment: the end of the beginning.

  2012cited by this paper
• Interaction Proteomics Identify NEURL4 and the HECT E3 Ligase HERC2 as Novel Modulators of Centrosome Architecture*

  2012cited by this paper
• NAHA, a Novel Hydroxamic Acid-Derivative, Inhibits Growth and Angiogenesis of Breast Cancer In Vitro and In Vivo

  2012cited by this paper
• Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study.

  2012cited by this paper
• The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage.

  2012cited by this paper
• p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.

  2012cited by this paper
• UbcH7 reactivity profile reveals Parkin and HHARI to be RING/HECT hybrids

  2011cited by this paper
• Anaphase‐promoting complex/cyclosome controls HEC1 stability

  2011cited by this paper
• Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells

  2011cited by this paper
• Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.

  2011cited by this paper
• The p73 Tumor Suppressor Is Targeted by Pirh2 RING Finger E3 Ubiquitin Ligase for the Proteasome-dependent Degradation*

  2011cited by this paper
• MDM2 and MDMX in cancer and development.

  2011cited by this paper
• PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility.

  2011cited by this paper
• Good COP1 or bad COP1? In vivo veritas.

  2011cited by this paper
• Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA.

  2011cited by this paper
• The elusive role of the SPRY2 domain in RyR1

  2011cited by this paper
• Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect

  2011cited by this paper
• Role of Pirh2 in Mediating the Regulation of p53 and c-Myc

  2011cited by this paper
• Mitochondrial Dysfunction in Parkinson's Disease

  2011influential reference
• Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT

  2011influential reference
• Pirh2 E3 Ubiquitin Ligase Monoubiquitinates DNA Polymerase Eta To Suppress Translesion DNA Synthesis

  2011cited by this paper
• SCFFBW 7 regulates cellular apoptosis by targeting MCL 1 for ubiquitylation and destruction

  2011influential reference
• Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.

  2011cited by this paper
• WWP1: a versatile ubiquitin E3 ligase in signaling and diseases

  2011cited by this paper
• Correlation between Skp2 expression and nodal metastasis in stage I and II oral squamous cell carcinomas.

  2011cited by this paper
• Insertional mutagenesis identifies multiple networks of co-operating genes driving intestinal tumorigenesis

  2011cited by this paper

• Targeting posttranslational modifications of oxidative stress pathways for the treatment of diabetic nephropathy

  2026cites this paper
• FOXM1 Signaling Network Transcriptionally Upregulates Expression of Proteins Involved in Mitotic Progression to Induce High Proliferation and Chromosomal Instability in Androgen Receptor-Low Triple-Negative Breast Cancer.

  2026cites this paper
• TRIM40 Drives Pathological Cardiac Hypertrophy and Heart Failure via Ubiquitination of PKN2.

  2026cites this paper
• Characterization of RNF144B and PPP2R2A identified by a novel approach using TCGA data in ovarian cancer

  2025cites this paper
• HECW1 Gene's Role in Gastric Cancer Prognosis and Its Suppressive Effect on Cell Progression after Knockdown.

  2025cites this paper
• E3 ubiquitin ligases and their therapeutic potential in disease Management.

  2025cites this paper
• Combating Malaria: Targeting the Ubiquitin-Proteasome System to Conquer Drug Resistance

  2025cites this paper
• Knockdown of TRIM47 Overcomes Paclitaxel Resistance in Ovarian Cancer by Suppressing the TGF‐β Pathway via PPM1A

  2025cites this paper
• Deubiquitylating Enzymes in Hepatocellular Carcinoma

  2025cites this paper
• A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features

  2025cites this paper
• DTX3L E3 ligase: Molecular functions, regulatory mechanisms, and potential as a novel cancer biomarker and therapeutic target.

  2025cites this paper
• E3 ubiquitin ligases in signaling, disease, and therapeutics.

  2025cites this paper
• Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer

  2025cites this paper
• Ubiquitin-specific proteases in pancreatic cancer: Molecular regulators of tumor progression and therapy resistance.

  2025cites this paper
• Regulation of NLRP3/TRIM family signaling in gut inflammation and colorectal cancer.

  2025cites this paper
• Molecular Glues in Immunotherapy: Fine-Tuning Immune Responses for Precision Medicine.

  2025cites this paper
• Research progress of DUB enzyme in breast cancer

  2025cites this paper
• The ubiquitin-proteasome system in Alzheimer’s disease: mechanism of action and current status of treatment

  2025cites this paper
• Development of the fluorescence polarization-based competition assay for the E3 ligase GID4.

  2025cites this paper
• E3 Ubiquitin Ligases: Structures, Biological Functions, Diseases, and Therapy

  2025cites this paper
• Proteomic Characterization of NEDD4 Unveils Its Potential Novel Downstream Effectors in Gastric Cancer.

  2025cites this paper
• Proteasomal Dysfunction in Cancer: Mechanistic Pathways and Targeted Therapies

  2025cites this paper
• TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO

  2024cites this paper
• RNF123 inhibits cell viability, cell cycle and colony formation of breast cancer by inhibiting glycolysis via ubiquitination of PFKP

  2024cites this paper
• Hypoxic and acidic tumor microenvironment-driven AVL9 promotes chemoresistance of pancreatic ductal adenocarcinoma via the AVL9-IκBα-SKP1 complex.

  2024cites this paper
• TRIM47 inhibits cisplatin chemosensitivity and endoplasmic reticulum stress-induced apoptosis of ovarian cancer cells.

  2024cites this paper
• Construction and validation of a ubiquitination-related prognostic risk score signature in breast cancer

  2024cites this paper
• The Role of Ubiquitination in Osteosarcoma Development and Therapies

  2024cites this paper
• NEDD4 and NEDD4L: Ubiquitin Ligases Closely Related to Digestive Diseases

  2024cites this paper
• CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathway

  2024cites this paper
• Brusatol's anticancer activity and its molecular mechanism: a research update.

  2024cites this paper
• TRIM21/USP15 balances ACSL4 stability and the imatinib resistance of gastrointestinal stromal tumors

  2024cites this paper
• Ubiquitin-proteasome system-mediated ubiquitination modification patterns and characterization of tumor microenvironment infiltration, stemness and cellular senescence in low-grade glioma

  2023cites this paper
• E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression

  2023cites this paper
• Methods to Evaluate the Effects of HAT/KAT Inhibition on SIAH2-Driven Reactive Oxygen Species Generation in Helicobacter pylori-Infected Gastric Epithelial Cells.

  2023cites this paper
• E3-ubiquitin ligases and recent progress in osteoimmunology

  2023cites this paper
• WWP1 E3 ligase at the crossroads of health and disease

  2023cites this paper
• E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities.

  2023cites this paper
• FOXA2 Suppression by TRIM36 Exerts Anti‐Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4‐Regulated Ferroptosis

  2023cites this paper
• Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice

  2023cites this paper
• TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway

  2023cites this paper
• The ubiquitin-proteasome system in breast cancer.

  2023cites this paper
• Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors

  2023cites this paper
• Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme

  2022cites this paper
• Pan-cancer illumination of TRIM gene family reveals immunology regulation and potential therapeutic implications

  2022cites this paper
• UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis

  2022cites this paper
• E3 ubiquitin ligases in the acute leukemic signaling pathways

  2022cites this paper
• Network models of protein phosphorylation, acetylation, and ubiquitination connect metabolic and cell signaling pathways in lung cancer

  2022cites this paper
• E3 Ubiquitin Ligases: Potential Therapeutic Targets for Skeletal Pathology and Degeneration

  2022cites this paper
• RING-finger E3 ligases regulatory network in PI3K/AKT-mediated glucose metabolism

  2022cites this paper
• Impact of a Single Nucleotide Polymorphism on the 3D Protein Structure and Ubiquitination Activity of E3 Ubiquitin Ligase Arkadia

  2022cites this paper
• FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells

  2022cites this paper
• Functional roles of E3 ubiquitin ligases in prostate cancer

  2022cites this paper
• Research Progress of DUB Enzyme in Hepatocellular Carcinoma

  2022cites this paper
• Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy.

  2022cites this paper
• Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review)

  2022cites this paper
• STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells

  2022cites this paper
• E2UbcH5B-derived peptide ligands target HECT E3-E2 binding site and block the Ub-dependent SARS-CoV-2 egression: A computational study

  2022cites this paper
• RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma

  2022cites this paper
• RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop

  2022cites this paper
• CRL2KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression

  2022cites this paper
• The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer

  2022cites this paper
• Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases

  2022cites this paper
• The Emerging Role of OTUB2 in Diseases: From Cell Signaling Pathway to Physiological Function

  2022cites this paper
• Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis.

  2022cites this paper
• The CBL-LSD1-CXCL8 axis regulates methionine metabolism in glioma.

  2022cites this paper
• Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression

  2022cites this paper
• MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells

  2021cites this paper
• Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance

  2021cites this paper
• Recent insight into the role of RING-finger E3 ligases in glioma.

  2021cites this paper
• The Roles of the Ubiquitin–Proteasome System in the Endoplasmic Reticulum Stress Pathway

  2021cites this paper
• Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment

  2021cites this paper
• E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential

  2021cites this paper
• The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance

  2021cites this paper
• The translational values of TRIM family in pan-cancers: from functions and mechanisms to clinics.

  2021cites this paper
• Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma

  2021cites this paper
• The Ubiquitin Proteasome System in Genome Stability and Cancer

  2021cites this paper
• The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression

  2021cites this paper
• Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function.

  2021cites this paper
• Bifunctional modalities for repurposing protein function.

  2021cites this paper
• RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis.

  2021cites this paper
• Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of NEDD4L in clear-cell renal cell cancer

  2021cites this paper
• Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in Pancreatic Cancer

  2021cites this paper
• The role of Siah2 in tumorigenesis and cancer therapy.

  2021cites this paper
• Ubiquitin/Proteasome

  2021cites this paper
• MEKK5 Interacts with and Negatively Regulates the E3 Ubiquitin Ligase NEDD4 for Mediating Lung Cancer Cell Migration

  2021cites this paper
• SOCS proteins and their roles in the development of glioblastoma

  2021cites this paper
• VLX1570 regulates the proliferation and apoptosis of human lung cancer cells through modulating ER stress and the AKT pathway

  2021cites this paper
• Fungal Secondary Metabolites as Inhibitors of the Ubiquitin–Proteasome System

  2021cites this paper
• Siah1 in cancer and nervous system diseases (Review).

  2021influential citation
• Identi cation of CDC20 As an Immune In ltration- Correlated Prognostic Biomarker in Hepatocellular Carcinoma

  2021cites this paper
• RBR E3 ubiquitin ligases in tumorigenesis.

  2020cites this paper
• Cyclin F Downregulation Affects Epithelial-Mesenchymal Transition Increasing Proliferation and Migration of the A-375 Melanoma Cell Line

  2020cites this paper
• UBR7 functions with UBR5 in the Notch signaling pathway and is involved in a neurodevelopmental syndrome with epilepsy, ptosis, and hypothyroidism.

  2020cites this paper
• Regulation of Epithelial–Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer

  2020cites this paper
• Ubiquitination in cancer stem cell: roles and targeted cancer therapy

  2020cites this paper
• Identification of Candidate Biomarkers for Salt Sensitivity of Blood Pressure by Integrated Bioinformatics Analysis

  2020cites this paper
• Targeting post-translational modification of transcription factors as cancer therapy.

  2020cites this paper
• The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma

  2020cites this paper
• The ubiquitin-proteasome pathway and resistance mechanisms developed against the proteasomal inhibitors in cancer cells.

  2020cites this paper